<p><strong>Hepatic Impairment:</strong>&nbsp;The safety and pharmacokinetics in patients with hepatic impairment have not been evaluated.<br />
<br />
<strong>Renal Impairment:</strong>&nbsp;Dose adjustment is recommended for patients with a serum creatinine clearance &lt;30 mL/min.<br />
<br />
<strong>Geriatric Use:</strong>&nbsp;The safety of Oseltamivir Phosphate has been established in clinical studies.<br />
<br />
<strong>Pediatric Use:</strong>&nbsp;The safety and efficacy of Oseltamivir Phosphate in pediatric patients younger than 1 year of age have not been studied. Oseltamivir Phosphate is not indicated for either treatment or prophylaxis of influenza in pediatric patients younger than 1 year of age.</p>